mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.004 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.004 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |